SCHEMBL2654907

SCHEMBL2654907

CC(C)Oc1cc(Oc2cccc(F)c2)cc(C(=O)Nc2ccc(C(=O)O)cn2)c1

nearest known ligand 0.81

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.81
RARG P13631 2/20 0.68
RARA P10276 1/20 0.66
RARB P10826 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2654226 0.92 GCK (0.81) GCKRARGRARARARB
SCHEMBL14366918 0.91 GCK (0.71) GCKRARGRARARARB
SCHEMBL2652999 0.90 GCK (1.00) GCKRARGRARARARB
SCHEMBL5653792 0.89 GCK (1.00) GCKRARGRARARARB
SCHEMBL2667569 0.88 GCK (0.66) GCKRARGRARARARB
SCHEMBL14505778 0.87 GCK (0.85) GCKRARGRARARARB
SCHEMBL2653232 0.83 GCK (0.69) GCKRARGRARARARB
SCHEMBL2666370 0.82 GCK (0.78) GCKRARGRARARARB
SCHEMBL2666372 0.82 GCK (0.83) GCKRARGRARARARB
SCHEMBL14366917 0.82 GCK (0.84) GCKRARGRARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070255062-A1 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators ASTRAZENECA AB (SE) 2007-11-01 US claimed
EP-1697324-A1 BENZOYL AMINO PYRIDYL CARBOXYLIC ACID DERIVATIVES USEFUL AS GLUCOKINASE (GLK) ACTIVATORS AstraZeneca AB (SE) 2006-09-06 EP claimed
WO-2005054200-A1 BENZOYL AMINO PYRIDYL CARBOXYLIC ACID DERIVATIVES USEFUL AS GLUCOKINASE (GLK) ACTIVATORS ASTRAZENECA AB (SE) 2005-06-16 WO claimed
US-20070255062-A1 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators ASTRAZENECA AB (SE) 2007-11-01 US disclosed
US-20070255062-A1 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators ASTRAZENECA AB (SE) 2007-11-01 US disclosed
US-20070255062-A1 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators ASTRAZENECA AB (SE) 2007-11-01 US disclosed
EP-1697324-A1 BENZOYL AMINO PYRIDYL CARBOXYLIC ACID DERIVATIVES USEFUL AS GLUCOKINASE (GLK) ACTIVATORS AstraZeneca AB (SE) 2006-09-06 EP disclosed
WO-2005054200-A1 BENZOYL AMINO PYRIDYL CARBOXYLIC ACID DERIVATIVES USEFUL AS GLUCOKINASE (GLK) ACTIVATORS ASTRAZENECA AB (SE) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070255062-A1 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators GCK, GALK1, PDXK GCK 1/4885RARG 3734/4885RARA 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.